Key result
Iloprost reported to treat PH secondary to sub-massive PE in two patient cases.
Why the study?
Patients with sub-massive pulmonary embolism have pulmonary hypertension with normal systemic arterial pressure and RV dysfunction, but treatment options remain unclear.
Does iloprost improve outcomes in patients with pulmonary hypertension due to sub-massive pulmonary embolism?
Does iloprost improve outcomes in patients with pulmonary hypertension due to sub-massive pulmonary embolism?
This report describes the use of iloprost in two patients with pulmonary hypertension secondary to sub-massive pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for iloprost in this setting; leaves open efficacy and should not change practice.
Patients with acute pulmonary embolism (PE) who has normal systemic arterial pressure and right ventricular (RV) dysfunction are considered to have sub-massive pulmonary embolism (SPE), with 3-mont...
No takes yet. Share an insight, caveat, or question.
Alsaghir et al. (2013) studied this question. Iloprost was reported as a treatment for pulmonary hypertension secondary to sub-massive pulmonary embolism in two patient cases.
Synapse has enriched 10 related papers. Consider them for comparative context: